Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase‐4 inhibitor plus low‐dose metformin: A multicenter, prospective, randomized, open‐label, paralle
Imeglimin in combination with a dipeptidyl peptidase-4 inhibitor and low-dose metformin improved HbA1c compared with metformin dose escalation.
Authors
- Akihiro Takahashi (ORCID: https://orcid.org/0000-0003-0410-3085)
- Hiroki Yokoyama (ORCID: https://orcid.org/0000-0003-1602-4050)
- Aika Miya (ORCID: https://orcid.org/0000-0002-3313-6946)
- Arina Miyoshi
- Reina Kameda
- Akinobu Nakamura (ORCID: https://orcid.org/0000-0002-8192-0006)
- Shinichiro Kawata
- Hiroshi Nomoto (ORCID: https://orcid.org/0000-0003-0713-221X)
- Sho Furusawa (ORCID: https://orcid.org/0009-0008-9509-7170)
- Kei Yokozeki (ORCID: https://orcid.org/0000-0002-8510-345X)
- Yuki Oe (ORCID: https://orcid.org/0000-0002-4947-5395)
- Hiraku Kameda (ORCID: https://orcid.org/0000-0003-1870-6688)
- Tatsuya Atsumi
- So Nagai
Institutions
- Asahikawa Medical University (JP)
- Hokkaido University (JP)
- NTT Medical Center (JP)
- Hoshigaoka Medical Center (JP)
- Sapporo City General Hospital (JP)
- National Institute of Technology, Tomakomai College (JP)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1111/dom.16150
- Citations
- 7
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.50